Bifurcation Lesions Market, By Product Type (One Stent and Two Stents), By Application (Peripheral Vascular and Coronary Vascular), and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2020-2026
REPORT HIGHLIGHT
Bifurcation lesions market was valued at USD 2.19 billion by 2018, growing with 6.3% CAGR during the forecast period, 2020-2026
Bifurcation lesion is the narrowing or the stenosis located in adjoining side-branch vessel and in the main coronary artery. Bifurcation lesion is also called as bifurcation blockage. At the site, where a vessel of side-branch comes off from the main coronary artery, fatty build-up and plaque are more likely to develop, due to the forces related to blood flow changes. The bifurcation lesions are a little challenging for cardiac interventionalists for treating the blockages that do not involve the vessels of side-branch. This is because the present stents do not come in a Y configuration. Although, the experienced interventionalists are developing a more specialized approach to personalize the patient treatment for these lesions, technically, this procedure is sometimes demanding.
Market Dynamics
Unhealthy lifestyle of people and growing geriatric population are some of the significant factors driving the growth of global bifurcation lesions market. In addition, commercialization & increase in approval of innovative devices, and the introduction of novel devices by top market vendors for treatment of bifurcation lesions are other factors impelling the market growth. Furthermore, growing demand for minimally invasive procedures, increasing affordability, and rising medical tourism are fuelling the demand for bifurcation lesions all over the globe. As per some studies, around 20% of total percutaneous coronary interventions comprise of coronary bifurcation lesions procedures. The governments of various developed and developing economies are taking initiatives for reimbursement which is predicted to propel the market growth.
Additionally, growing prevalence of lesions and ongoing clinical trials on balloons & stents for treatment of bifurcation lesions are likely to enhance the market growth during the forecast period. Also, the rise in the number of skilled surgeons and advancements in devices used for procedures and imaging are expected to impel the industry growth.
Product Type Takeaway
Based on product type, the global industry is categorized into one-stent and two-stent bifurcation lesions. Of these product type, the on-stent segment accounted for the largest market share in 2018 and is expected to dominate the market during the forecast period. This growth is mainly because in one-stent approach the main branch (MB) and the side branch (SB) is stented temporarily only if the clinical symptoms features warrant intervention. In addition, the one-stent product type is most preferred owing to equivalent clinical outcomes in both SB and MB stenting. On the other hand, the two-stent approach involves elective stenting of both SB and MB. Thus, the two-stent bifurcation lesions segment is expected to grow at a robust pace in the projected timeframe. Also, stent implantation is mostly preferred over balloon angioplasty for treating bifurcation lesions.
Application Takeaway
On the basis of application, the global industry is bifurcated into peripheral vascular and coronary vascular. In 2018, the coronary vascular segment registered the highest market share and is anticipated to grow impressively during the period of forecast. This is majorly due to the growing number of percutaneous procedures for coronary intervention, rise in awareness amongst individual regarding bifurcation lesions, and advancements in coronary bifurcation lesion products. In addition, the ongoing clinical trials and increasing investments by major market vendors are likely to propel the segment growth.
On the other hand, the peripheral vascular segment is anticipated to be the fastest-growing market in terms of growth rate by the end of 2026. This is primarily due to the growing prevalence of peripheral arterial diseases (PAD) and increasing awareness regarding this disease amongst individuals. The National Institute of Health (NIH) stated that the ratio amongst Americans who suffer from PAD is one in every 20 individuals.
Regional Takeaway
Depending on the geography, the global market is divided into Europe, Asia Pacific, North America, Latin America, and the Middle East & Asia. North America held the strongest position in the market in 2018 and is projected to continue the same throughout the forecast. This dominance can be attributed owing to favorable reimbursement policies, higher disposable income, and the presence of top market players in this region. Along with North America, the Europe market registered for the second-largest share owing to a number of government initiatives to enhance healthcare access and presence of major industry players in this region.
On the other hand, the Asia Pacific region is projected to experience the fastest growth by 2026 owing to rise in induced-lifestyle of people and rising elderly population in this region. The increase in the elderly population has resulted in a rise in coronary heart diseases, which is likely to impel the market growth. Furthermore, the rising adoption of newer technologies, growing awareness, and approval of various balloons are expected to create enormous growth opportunities in the Asia Pacific market.
Key Vendors Takeaway
Some of the major players functioning in the global bifurcation lesions market include Boston Scientific Corporation; Cardinal Health; Abbott; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Terumo Medical Corporation, and Spectranetics. These player are focusing on adopting several strategies such as new product developments, acquisitions, mergers, and collaborations to hold a strong position in the global industry.
For instance, in May 2018, Medtronic launched a study to evaluate the efficacy and safety of its Resolute Onyx DES. The aim of the company behind this launch was for treating the bifurcation lesions of patients suffering from coronary artery disease.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
BIFURCATION LESIONS MARKET KEY PLAYERS
- Boston Scientific Corporation
- Cardinal Health
- Abbott
- Medtronic
- Johnson & Johnson Services, Inc.
- R. Bard, Inc.
- Terumo Medical Corporation
- Spectranetics
- Others
BIFURCATION LESIONS MARKET, BY PRODUCT TYPE
- One-Stent
- Two-Stents
BIFURCATION LESIONS MARKET, BY APPLICATION
- Peripheral Vascular
- Coronary Vascular
BIFURCATION LESIONS MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. BIFURCATION LESIONS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Product Type
2.1.2. Market Snippet by Application
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. BIFURCATION LESIONS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. BIFURCATION LESIONS INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. BIFURCATION LESIONS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. BIFURCATION LESIONS MARKET – BY PRODUCT TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Product Type, 2019 & 2026 (%)
6.2. One-Stent
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Two-Stent
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. BIFURCATION LESIONS MARKET – BY APPLICATION
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
7.2. Peripheral Vascular
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Coronary Vascular
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. BIFURCATION LESIONS MARKET– BY GEOGRAPHY
8.1. Introduction
8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
8.2. North America
8.2.1. Overview
8.2.2. Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.2.4. North America Market Size and Forecast, By Product Type, 2015 – 2026 (US$ Million)
8.2.5. North America Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.2.6. U.S.
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.2.7. Canada
8.2.7.1. Overview
8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Product Type, 2015 – 2026 (US$ Million)
8.3.5. Europe Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.3.6. Germany
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.7. Italy
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.8. United Kingdom
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.9. France
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3.10. Rest of Europe
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2015 – 2026 (US$ Million)
8.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.7. China
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.8. Japan
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.9. South Korea
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4.10. Rest of APAC
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5. Latin America
8.5.1. Overview
8.5.2. Key Manufacturers in Latin America
8.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.5.4. Latin America Market Size and Forecast, By Product Type, 2015 – 2026 (US$ Million)
8.5.5. Asia Pacific Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.5.6. Brazil
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.7. Mexico
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.8. Argentina
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6. Middle East and Africa
8.6.1. Overview
8.6.2. Key Manufacturers in Middle East and Africa
8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
8.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2015 – 2026 (US$ Million)
8.6.5. Middle East and Africa Market Size and Forecast, By Application, 2015 – 2026 (US$ Million)
8.6.6. Saudi Arabia
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.6.7. United Arab Emirates
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Boston Scientific Corporation
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Cardinal Health
9.3. Abbott
9.4. Medtronic
9.5. Johnson & Johnson Services, Inc.
9.6. C. R. Bard, Inc.
9.7. Terumo Medical Corporation
9.8. Spectranetics
9.9. Others
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Bifurcation Lesions market: Product Type Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Product Type
TABLE Global Bifurcation Lesions market, by Product Type 2015-2026 (USD Million)
TABLE Bifurcation Lesions market: Application Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Bifurcation Lesions market, by Application 2015-2026 (USD Million)
TABLE Bifurcation Lesions market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Bifurcation Lesions market, by Region 2015-2026 (USD Million)
TABLE North America Bifurcation Lesions market, by Country, 2015-2026 (USD Million)
TABLE North America Bifurcation Lesions market, by Product Type, 2015-2026 (USD Million)
TABLE North America Bifurcation Lesions market, by Application, 2015-2026 (USD Million)
TABLE Europe Bifurcation Lesions market, by country, 2015-2026 (USD Million)
TABLE Europe Bifurcation Lesions market, by Product Type, 2015-2026 (USD Million)
TABLE Europe Bifurcation Lesions market, by Application, 2015-2026 (USD Million)
TABLE Asia Pacific Bifurcation Lesions market, by country, 2015-2026 (USD Million)
TABLE Asia Pacific Bifurcation Lesions market, by Product Type, 2015-2026 (USD Million)
TABLE Asia Pacific Bifurcation Lesions market, by Application, 2015-2026 (USD Million)
TABLE Latin America Bifurcation Lesions market, by country, 2015-2026 (USD Million)
TABLE Latin America Bifurcation Lesions market, by Product Type, 2015-2026 (USD Million)
TABLE Latin America Bifurcation Lesions market, by Application, 2015-2026 (USD Million)
TABLE Middle East and Africa Bifurcation Lesions market, by country, 2015-2026 (USD Million)
TABLE Middle East and Africa Bifurcation Lesions market, by Product Type, 2015-2026 (USD Million)
TABLE Middle East and Africa Bifurcation Lesions market, by Application, 2015-2026 (USD Million)
List of Figures
FIGURE Bifurcation Lesions market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Product Type segment market share analysis, 2019 & 2026
FIGURE Product Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE One-Stent market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Two-Stent market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Application segment market share analysis, 2019 & 2026
FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Peripheral Vascular market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Coronary Vascular market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Bifurcation Lesions market share and leading players, 2018
FIGURE Europe Bifurcation Lesions market share and leading players, 2018
FIGURE Asia Pacific Bifurcation Lesions market share and leading players, 2018
FIGURE Latin America Bifurcation Lesions market share and leading players, 2018
FIGURE Middle East and Africa Bifurcation Lesions market share and leading players, 2018
FIGURE North America market share analysis by country, 2018
FIGURE U.S. Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Bifurcation Lesions market share analysis by country, 2018
FIGURE Germany Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Bifurcation Lesions market share analysis by country, 2018
FIGURE India Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Bifurcation Lesions market share analysis by country, 2018
FIGURE Brazil Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Bifurcation Lesions market share analysis by country, 2018
FIGURE Saudi Arabia Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Bifurcation Lesions market size, forecast and trend analysis, 2015 to 2026 (USD Million)
